Clinical Trial Update: Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

View source ↗

Summary

Pfizer-sponsored real-world study evaluating the use and effectiveness of ritlecitinib for severe alopecia areata in the United States; recruitment has not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Ritlecitinib (ritlecitinib)

Snippet

Sponsor: Pfizer | Conditions: Alopecia Areata | Status: NOT_YET_RECRUITING